B Slocombe
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antibiotic Resistance in Bacteria 16
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 12
- Co-authors
- R. Sutherland (9 shared papers)Caroline Perry (2 shared papers)James William Gilbart (1 shared paper)Karen E. Griffin (4 shared papers)Ron Boon (1 shared paper)Alan R. White (1 shared paper)MICHAEL J. BASKER (5 shared papers)Anthony R. White (7 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (9 papers)Antimicrobial Agents and Chemotherapy (6 papers)Drugs (3 papers)Nature (2 papers)Journal of Clinical Pathology (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
B Slocombe
31 papers receiving 776 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 247
- Infectious Diseases 300
- Clinical Biochemistry 107
- Applied Microbiology and Biotechnology 28
- Pharmacology 234
Countries citing papers authored by B Slocombe
This map shows the geographic impact of B Slocombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Slocombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Slocombe more than expected).
Fields of papers citing papers by B Slocombe
This network shows the impact of papers produced by B Slocombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Slocombe. The network helps show where B Slocombe may publish in the future.
Co-authors
The 25 scholars most cited alongside B Slocombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 266 | |
| 2 | 1993 | 155 | |
| 3 | 1981 | 101 | |
| 4 | 1970 | 53 | |
| 5 | 1991 | 44 | |
| 6 | 1984 | 36 | |
| 7 | 1990 | 30 | |
| 8 | 1985 | 26 | |
| 9 | 1977 | 20 | |
| 10 | 1989 | 18 | |
| 11 | 1969 | 13 | |
| 12 | 1991 | 13 | |
| 13 | 1989 | 13 | |
| 14 | 1973 | 12 | |
| 15 | 1998 | 12 | |
| 16 | 1985 | 10 | |
| 17 | 1986 | 9 | |
| 18 | Beta-lactamase activity and resistance to ampicillin, carbenicillin, and cephaloridine of Klebsiella, Enterobacter, and Citrobacter. | 1969 | 6 |
| 19 | 1985 | 4 | |
| 20 | Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins. | 1989 | 4 |
About B Slocombe
B Slocombe is a scholar working on Molecular Medicine, Pharmacology, Molecular Biology, Epidemiology and Infectious Diseases, having authored 31 papers that have together received 871 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Essential Oils and Antimicrobial Activity (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Pneumonia and Respiratory Infections (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Molecular Medicine (247 citations), Infectious Diseases (300 citations), Clinical Biochemistry (107 citations), Applied Microbiology and Biotechnology (28 citations) and Pharmacology (234 citations). B Slocombe has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include R. Sutherland, Caroline Perry, James William Gilbart, Karen E. Griffin, Ron Boon, Alan R. White, MICHAEL J. BASKER, Anthony R. White, Stephen W. Elson and Robert Edmondson. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Drugs, Nature and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.